These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33908272)

  • 1. FDA expedited approval and implications for rational formulary and health plan design.
    Ferries EA; Fleming WK; Shrank WH
    J Manag Care Spec Pharm; 2021 May; 27(5):682-684. PubMed ID: 33908272
    [No Abstract]   [Full Text] [Related]  

  • 2. Biosimilar Products in the Modern U.S. Health Care and Regulatory Landscape.
    Peterson J; Budlong H; Affeldt T; Skiermont K; Kyllo G; Heaton A
    J Manag Care Spec Pharm; 2017 Dec; 23(12):1255-1259. PubMed ID: 29172981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing patient access to pharmaceuticals in the UK and US.
    Cohen J; Cairns C; Paquette C; Faden L
    Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Few new drugs deserve expedited regulatory treatment.
    Darrow JJ
    J Manag Care Spec Pharm; 2021 May; 27(5):685-688. PubMed ID: 33908278
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical models for formulary committees.
    Lapuerta P
    Value Health; 2001; 4(5):347. PubMed ID: 11705124
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes of ticagrelor formulary tiers in the USA: targeting private insurance providers away from government-funded plans.
    Serebruany VL; Dinicolantonio JJ
    Cardiology; 2013; 126(3):187-90. PubMed ID: 24030166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors.
    Wang YR; Pauly MV
    Manag Care Interface; 2005 Aug; 18(8):39-45. PubMed ID: 16127891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulary decisions for pre-1938 medications.
    Culley CM; Carroll BA; Skledar SJ
    Am J Health Syst Pharm; 2008 Jul; 65(14):1363-7. PubMed ID: 18593683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Military brings order to formulary system.
    Berberabe T
    Manag Care; 2004 Nov; 13(11):28-30. PubMed ID: 15595398
    [No Abstract]   [Full Text] [Related]  

  • 12. Mibefradil and an effective formulary system.
    Vermeulen LC; Dunham DB
    Am J Health Syst Pharm; 1998 Sep; 55(18):1934-5. PubMed ID: 9784776
    [No Abstract]   [Full Text] [Related]  

  • 13. United States pharmacopeia development of the Medicare model formulary guidelines.
    Bielory L;
    Am J Geriatr Cardiol; 2005; 14(6):301-7. PubMed ID: 16276127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulary tiers, medication cost sharing, and transparency in bronze and silver qualified health plans in 2014 vs 2018.
    Hung A; Sauvageau G
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1332-1340. PubMed ID: 34595951
    [No Abstract]   [Full Text] [Related]  

  • 15. Placement of selected new FDA-approved drugs in Medicare Part D formularies, 2009-2013.
    Stuart BC; Tom SE; Choi M; Johnson A; Sun K; Qato D; Obi EN; Zacker C; Park Y; Arcona S
    Am J Manag Care; 2018 Jun; 24(6):e175-e182. PubMed ID: 29939507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' views of formularies: implications for Medicare drug benefit design.
    Landon BE; Reschovsky JD; Blumenthal D
    Health Aff (Millwood); 2004; 23(1):218-26. PubMed ID: 15002646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the drug formulary in a valve-based pharmacy benefit.
    Giaquinta D
    Manag Care Interface; 2005 Aug; 18(8):37-8. PubMed ID: 16127890
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicaid patients' access to new drugs.
    Grabowski H
    Health Aff (Millwood); 1988; 7(5):102-14. PubMed ID: 3068107
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing psychotropic drug costs: will formularies work?
    Huskamp HA
    Health Aff (Millwood); 2003; 22(5):84-96. PubMed ID: 14515884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for developing a successful Medicare part D formulary.
    Stefanacci RG
    Manag Care; 2005 May; 14(5 Suppl):3-10. PubMed ID: 15962831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.